L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
Active, not recruiting · NCT03982160 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Phase 4 | 2026-06-18 | NCT03982160 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Texas at Arlington | 16 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Delaware | Newark | United States | 4 |
| UT Southwestern | Dallas | United States | 33 |